article thumbnail

5 strategies for biotech startups to outlast a market downturn

TechCrunch

James Coates is the Health and Human Performance principal at Decisive Point , a venture capital and advisory firm that invests in and supports startups with emerging defense technologies. This is especially true for biotech startups, where investment needs are higher and success timelines can be much longer.

Biotech 231
article thumbnail

Biotech Boom: Executive Search Strategies in Life Sciences

N2Growth Blog

With the constant advancements in technology and research, businesses in this sector require leaders who possess a deep understanding of the scientific landscape and the business acumen to drive growth and innovation. The life sciences industry is known for its unique challenges in recruiting and hiring.

Biotech 175
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

6 investors discuss why AI is more than just a buzzword in biotech

TechCrunch

That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or other these days. But despite becoming quite the buzzword, AI’s apparent ubiquity in biotech isn’t actually driving deal flow or higher valuations.

Biotech 242
article thumbnail

In an increasingly hot biotech market, protecting IP is key

TechCrunch

2021 should be a banner year for biotech startups that make smart choices early. After a record year for biotech investment in 2020 — during which the industry saw $28.5 Since 1996 , 14,000 startups have licensed technology out of those universities, and 67% of licenses were taken by startups or small companies. Kevin O’Connor.

Biotech 240
article thumbnail

The 10 Biggest Rounds Of March: Wonder, Biotech Headline Big Month

Crunchbase News

Wonder ’s big $700 million raise may have captured most people’s attention last month, but the story when it came for large deals was really biotech. Mirador Therapeutics , $400M, biotech: It was a huge month for big biotech raises and this was the biggest. Check out the biggest rounds of last month here.

Biotech 108
article thumbnail

5 ways biotech startups can mitigate risk to grow sustainably in the long run

TechCrunch

Omar Khalil is a partner at Santé Ventures , where he focuses primarily on biotechnology and medical technology companies. Capital is the fuel that advances scientific and technological innovation, and it means a life science startup can create products that benefit the world at large. Omar Khalil. Contributor. Share on Twitter.

Biotech 242
article thumbnail

Life Sciences Executive Search Firms: Bridging Biotech and Leadership

N2Growth Blog

Understanding the Unique Challenges of Biotech Leadership Recruitment Organizations face some unique challenges when it comes to leadership recruitment in the biotech space. Navigating these unique challenges in biotech leadership recruitment requires a comprehensive understanding of the industry, its trends, and specific needs.

Biotech 94